跳至主要内容
临床试验/CTRI/2020/08/027013
CTRI/2020/08/027013已完成2 期

Clinical study to evaluate the Efficacy and safety of ROSELLE in patients with Bronchial asthma and Malnutrition.

DXN Manufacturing India Pvt Ltd0 个研究点目标入组 12 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
12

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patients aged 18-59 years(both sex) suffering from mild and moderate-persistent bronchial asthma characterized by
  • -Daily symptoms of asthma
  • -Nocturnal awakenings more than once per week
  • -Daily need for SABAs for symptom relief
  • -More than just minor limitation in normal activity
  • -FEV1 between 60 and 80 percent of predicted and an FEV/FVC ratio less than the lower confidence interval for normal

排除标准

  • Patients with fever, drug-induced asthma, aspirin intolerance triad, asthma with fixed airflow limitation, asthma with obesity, late-onset asthma will be excluded.
  • -History of heart, liver, kidney, or other organ diseases;
  • -Allergy or intolerance to the individual constituents in NONIZHI
  • -Subjects who are pregnant and lactating mothers, or with any serious or invalidating other disease limiting full adhesion to the protocol.
  • -Participation in an investigational drug trial in the 30 days prior to the screening visit.

研究者

发起方
DXN Manufacturing India Pvt Ltd

相似试验

se of Roselle in Bronchial asthma and Malnutritio | 临床试验